Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: A paraffin immunohistochemical study

Modern Pathology

Volumn 12, Issue 4, 1999, Pages 412-416

  Vasef, Mohammad A ^a,c   Brynes, Russell K ^b   Sturm, Mary ^a   Bromley, Christine ^a   Robinson, Robert A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Cyclin D1 protein; Immunohistochemistry; Parathyroid adenoma; Parathyroid carcinoma; Parathyroid hyperplasia

Indexed keywords

CYCLIN D1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CYCLIN D1; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID NEOPLASMS;

EID: 0032938805     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Mol Pathol 1998;51:1-7.
2. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83:2034-40.
3. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991;6:449-53.
4. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl-1-linked candidate oncogene. Nature 1991;350:512-5.
5. de Boer CJ, van Krieken JHJM, Kluin-Nelemans HC, Kluin PM, Schuuring E. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 1995;10: 1833-40.
6. Bosch F, Campo E, Jares P, Pittaluga S, Munoz J, Nayach I, et al. Increased expression of PRAD-1/CCND-1 gene in hairy cell leukemia. Br J Haematol 1995;1025-30.
7. Kobayashi H, Kitano K, Saito H, Aoki K, Narita A, Terada N, et al. Overexpression of PRAD-1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;32). Cancer Genet Cytogenet 1995;84:69-72.
8. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, et al. PRAD-1 / cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726-32.
9. Kobayashi H, Saito H, Kitano K, Kiyosawa K, Gaun S, Aoki K, et al. Overexpression of PRAD-1 oncogene in a patient with multiple myeloma and t(11;14)(q13;32). Acta Haematol 1995; 94:199-203.
10. Yang W, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (bcl-1, PRAD-1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
11. Banno S, Yoshikawa K, Nakamura S, Yamamoto K, Seito T, Nitta M, et al. Monoclonal antibody against PRAD-1 / cyclin D1 stains nuclei of tumor cells with translocation or amplification at bcl-1 locus. Jpn J Cancer Res 1994;85:918-26.
12. Zukerberg LR, Yang W, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphoma. Detection by immunohistochemistry. Am J Clin Pathol 1995;103:756-60.
13. Vasef MA, Medeiros LJ, Koo C, McCourty A, Brynes RK. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Am J Clin Pathol 1997;108: 302-7.
14. Vasef MA, Medeiros LJ, Yospur LS, Sun NCJ, McCourty A, Brynes RK. Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod Pathol 1997;10:927-32.
15. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD et al. Determination of prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11:885-91.
16. Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994;102:695-8.
17. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994;54:3107-10.
18. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WDJ, Cerny T, et al. Prognostic significance of CCND-1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br J Cancer 1996;73:294-300.
19. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161-9.
20. Hsi ED, Zukerberg LR, Yang W-I, Arnold A. Cyclin D1 / PRAD-1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 1996;81:1736-9.
21. Schantz A, Castleman B. Parathyroid carcinoma: a study of 70 cases. Cancer 1973;31:600-5.
22. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95:2047-53.